Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting.

Autor: Ito, Tomoki1 (AUTHOR) itot@hirakata.kmu.ac.jp, Hashimoto, Yoshinori2 (AUTHOR), Tanaka, Yasuhiro3 (AUTHOR), Nakaya, Aya1 (AUTHOR), Fujita, Shinya1 (AUTHOR), Satake, Atsushi1 (AUTHOR), Nakanishi, Takahisa1 (AUTHOR), Konishi, Akiko1 (AUTHOR), Hotta, Masaaki1 (AUTHOR), Yoshimura, Hideaki1 (AUTHOR), Ishii, Kazuyoshi1 (AUTHOR), Hashimoto, Akiko3 (AUTHOR), Kondo, Toshinori4 (AUTHOR), Omura, Hiromi2 (AUTHOR), Shinzato, Isaku3 (AUTHOR), Tanaka, Takayuki2 (AUTHOR), Nomura, Shosaku1 (AUTHOR)
Zdroj: European Journal of Haematology. Aug2019, Vol. 103 Issue 2, p116-123. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje
načítá se...